Inari Medical (NASDAQ:NARI – Free Report) had its target price lowered by Wells Fargo & Company from $100.00 to $84.00 in a report released on Wednesday morning, Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. Several other analysts have also commented on the stock. Canaccord Genuity Group reaffirmed a […]